La disponibilidad de una forma oral para la semaglutida mejora su accesibilidad y conveniencia, lo que la convierte en una opcin verstil para el control del peso y el cuidado de la diabetes
Follow a gradual dose escalation schedule to minimize gastrointestinal side effects: Weeks 1-4: 0.25 mg Weeks 5-8: 0.5 mg Weeks 9-12: 1 mg Weeks 13-16: 1.7 mg From Week 17 onwards: 2.4 mg (maintenance dose) Rotate injection sites to prevent skin irritation or reactions
However, it doesnt come without the risk of drug interactions, which could decrease its effectiveness or cause harmful side effects
Many patients and physicians now view GLP-1 therapy as an ongoing treatment for weight management, similar to blood-pressure or cholesterol medication
Eli Lilly is the manufacturer of tirzepatide and dulaglutide drugs
American Pharmacists Association: Frequently Asked Questions About Pharmaceutical Compounding Pew Research Center: What Are Compounded Drugs, and How Can They Be Kept Safe